NCBiotech News

NCBiotech and a statewide coalition of partners are a Phase 1 recipient of up to $500,000 in the U.S. EDA’s $1 billion Build Back Better Regional Challenge.

Five years after launching with a team headlined by local life sciences “rainmaker” Steve Butts and $49 million in capital, Morrisville-based Arrivo BioVentures is emerging from stealth mode with four drugs in its pipeline.

Quebec-based Mispro Biotech Services says it will open a new RTP vivarium in early 2022 to support North Carolina’s globally recognized life sciences research community.

Medicago, a Canadian biopharmaceutical company with manufacturing operations in Durham, is reporting positive results from a Phase 3 clinical trial of its potential COVID-19 vaccine made in plants.

Thermo Fisher Scientific says is planning to build a 375,000-square-foot manufacturing plant in Mebane that will create 150 to 200 jobs, with help from a $192.5 million federal contract.

GreenLight Biosciences, which has a growing research and development presence in Research Triangle Park, has announced additional financing on its journey to becoming a publicly traded company

Durham-based BioCryst Pharmaceuticals has reached agreements that will provide the company with $350 million in funding to support the development of two of its new drugs.

Regulatory authorities in Mexico have approved RTP ag tech company Vestaron’s SPEAR-Lep, a biopesticide that’s already in use in the U.S.

Durham-based Cell Microsystems has received $10 million in financing from life science and venture capital firm Telegraph Hill Partners.

Sheila Mikhail, co-founder and CEO of AskBio and an NCBiotech board member, has been named national Entrepreneur of the Year by Ernst & Young.

Raleigh-based Aceragen, a biopharmaceutical company developing therapeutics for rare and orphan diseases, has acquired Arrevus, another Raleigh company with a similar focus.

Cleanroom design and construction company AdvanceTEC has announced it will invest $10 million in a new prefabrication and modularization facility in Johnston County.

Contract research organization Portrett Pharmaceuticals has launched a new lab in Wilmington that specializes in the analytical testing of small-molecule active pharmaceutical ingredients.

The North Carolina Biotechnology Center awarded 11 grants and loans totaling $779,300 to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year.

A month after a favorable ruling in a patent dispute, Morrisville-based Liquidia has gained tentative approval from the FDA for Yutrepia, its inhalation powder for treating pulmonary arterial hypertensio